世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

整形外科オンコロジーの世界市場の洞察と2028年までの予測


Global Orthopaedic Oncology Market Insights and Forecast to 2028

整形外科腫瘍学は、骨や軟部組織の腫瘍の検出、治療、フォローアップを扱う整形外科の新しいサブスペシャリティです。 市場分析と洞察。整形外科腫瘍学の世界市場 整形外科オンコロジーの世界市場規模は、2021... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2022年1月21日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

整形外科腫瘍学は、骨や軟部組織の腫瘍の検出、治療、フォローアップを扱う整形外科の新しいサブスペシャリティです。
市場分析と洞察。整形外科腫瘍学の世界市場
整形外科オンコロジーの世界市場規模は、2021年の百万米ドルから2028年には百万米ドルに達すると予測され、2022年から2028年の間、年率％で推移すると考えられます。
この健康危機による経済的変化を十分に考慮すると、2021年に整形外科腫瘍学の世界市場の％を占めていた外科は、COVID-19後の期間に改訂された％のCAGRで成長し、2028年には100万米ドルになると予測されます。一方、病院のセグメントは、この予測期間中、年率％で変化しています。
中国の整形外科オンコロジーの市場規模は2021年に百万米ドル、北米と欧州の整形外科オンコロジーはそれぞれ百万米ドルと百万米ドルとなっています。2021年の北米の割合は%で、中国とヨーロッパはそれぞれ%と%で、2028年には中国の割合が%に達し、分析期間中のCAGRは%になると予測されています。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパの整形外科オンコロジー市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%です。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の整形外科オンコロジー市場で得られる主要な機会を明らかにし、プレイヤーが市場で確固たる地位を築くのに役立つことを目的としています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には収益面での整形外科オンコロジーの世界市場全体のサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界の整形外科オンコロジー市場で永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の整形外科オンコロジー市場を詳細に調査するために、独自の業界最高水準の調査・分析アプローチを採用しました。
整形外科オンコロジーの世界的な範囲と市場規模
整形外科オンコロジー市場は、プレイヤー別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界の整形外科オンコロジー市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てています。
タイプ別セグメント
外科手術
化学療法
放射線療法
標的療法
用途別セグメント
病院
研究所
会社別
Stryker Corporation
アムジェン・インク
タイコエレクトロニクスUKホールディングス株式会社
アクセンタス株式会社
キヤノンメディカルシステムズ
シーメンス・ヘルシネアーズ
MDアンダーソンがんセンター
ロシュ
ノバルティスAG
サノフィS.A.
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orthopaedic Oncology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Surgery
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Orthopaedic Oncology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Research Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Orthopaedic Oncology Market Perspective (2017-2028)
2.2 Orthopaedic Oncology Growth Trends by Region
2.2.1 Orthopaedic Oncology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Orthopaedic Oncology Historic Market Size by Region (2017-2022)
2.2.3 Orthopaedic Oncology Forecasted Market Size by Region (2023-2028)
2.3 Orthopaedic Oncology Market Dynamics
2.3.1 Orthopaedic Oncology Industry Trends
2.3.2 Orthopaedic Oncology Market Drivers
2.3.3 Orthopaedic Oncology Market Challenges
2.3.4 Orthopaedic Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Orthopaedic Oncology Players by Revenue
3.1.1 Global Top Orthopaedic Oncology Players by Revenue (2017-2022)
3.1.2 Global Orthopaedic Oncology Revenue Market Share by Players (2017-2022)
3.2 Global Orthopaedic Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Orthopaedic Oncology Revenue
3.4 Global Orthopaedic Oncology Market Concentration Ratio
3.4.1 Global Orthopaedic Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orthopaedic Oncology Revenue in 2021
3.5 Orthopaedic Oncology Key Players Head office and Area Served
3.6 Key Players Orthopaedic Oncology Product Solution and Service
3.7 Date of Enter into Orthopaedic Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Orthopaedic Oncology Breakdown Data by Type
4.1 Global Orthopaedic Oncology Historic Market Size by Type (2017-2022)
4.2 Global Orthopaedic Oncology Forecasted Market Size by Type (2023-2028)
5 Orthopaedic Oncology Breakdown Data by Application
5.1 Global Orthopaedic Oncology Historic Market Size by Application (2017-2022)
5.2 Global Orthopaedic Oncology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Orthopaedic Oncology Market Size (2017-2028)
6.2 North America Orthopaedic Oncology Market Size by Type
6.2.1 North America Orthopaedic Oncology Market Size by Type (2017-2022)
6.2.2 North America Orthopaedic Oncology Market Size by Type (2023-2028)
6.2.3 North America Orthopaedic Oncology Market Share by Type (2017-2028)
6.3 North America Orthopaedic Oncology Market Size by Application
6.3.1 North America Orthopaedic Oncology Market Size by Application (2017-2022)
6.3.2 North America Orthopaedic Oncology Market Size by Application (2023-2028)
6.3.3 North America Orthopaedic Oncology Market Share by Application (2017-2028)
6.4 North America Orthopaedic Oncology Market Size by Country
6.4.1 North America Orthopaedic Oncology Market Size by Country (2017-2022)
6.4.2 North America Orthopaedic Oncology Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Orthopaedic Oncology Market Size (2017-2028)
7.2 Europe Orthopaedic Oncology Market Size by Type
7.2.1 Europe Orthopaedic Oncology Market Size by Type (2017-2022)
7.2.2 Europe Orthopaedic Oncology Market Size by Type (2023-2028)
7.2.3 Europe Orthopaedic Oncology Market Share by Type (2017-2028)
7.3 Europe Orthopaedic Oncology Market Size by Application
7.3.1 Europe Orthopaedic Oncology Market Size by Application (2017-2022)
7.3.2 Europe Orthopaedic Oncology Market Size by Application (2023-2028)
7.3.3 Europe Orthopaedic Oncology Market Share by Application (2017-2028)
7.4 Europe Orthopaedic Oncology Market Size by Country
7.4.1 Europe Orthopaedic Oncology Market Size by Country (2017-2022)
7.4.2 Europe Orthopaedic Oncology Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Orthopaedic Oncology Market Size (2017-2028)
8.2 Asia-Pacific Orthopaedic Oncology Market Size by Type
8.2.1 Asia-Pacific Orthopaedic Oncology Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Orthopaedic Oncology Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Orthopaedic Oncology Market Share by Type (2017-2028)
8.3 Asia-Pacific Orthopaedic Oncology Market Size by Application
8.3.1 Asia-Pacific Orthopaedic Oncology Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Orthopaedic Oncology Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Orthopaedic Oncology Market Share by Application (2017-2028)
8.4 Asia-Pacific Orthopaedic Oncology Market Size by Region
8.4.1 Asia-Pacific Orthopaedic Oncology Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Orthopaedic Oncology Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Orthopaedic Oncology Market Size (2017-2028)
9.2 Latin America Orthopaedic Oncology Market Size by Type
9.2.1 Latin America Orthopaedic Oncology Market Size by Type (2017-2022)
9.2.2 Latin America Orthopaedic Oncology Market Size by Type (2023-2028)
9.2.3 Latin America Orthopaedic Oncology Market Share by Type (2017-2028)
9.3 Latin America Orthopaedic Oncology Market Size by Application
9.3.1 Latin America Orthopaedic Oncology Market Size by Application (2017-2022)
9.3.2 Latin America Orthopaedic Oncology Market Size by Application (2023-2028)
9.3.3 Latin America Orthopaedic Oncology Market Share by Application (2017-2028)
9.4 Latin America Orthopaedic Oncology Market Size by Country
9.4.1 Latin America Orthopaedic Oncology Market Size by Country (2017-2022)
9.4.2 Latin America Orthopaedic Oncology Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Orthopaedic Oncology Market Size (2017-2028)
10.2 Middle East & Africa Orthopaedic Oncology Market Size by Type
10.2.1 Middle East & Africa Orthopaedic Oncology Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Orthopaedic Oncology Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Orthopaedic Oncology Market Share by Type (2017-2028)
10.3 Middle East & Africa Orthopaedic Oncology Market Size by Application
10.3.1 Middle East & Africa Orthopaedic Oncology Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Orthopaedic Oncology Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Orthopaedic Oncology Market Share by Application (2017-2028)
10.4 Middle East & Africa Orthopaedic Oncology Market Size by Country
10.4.1 Middle East & Africa Orthopaedic Oncology Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Orthopaedic Oncology Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Stryker Corporation
11.1.1 Stryker Corporation Company Details
11.1.2 Stryker Corporation Business Overview
11.1.3 Stryker Corporation Orthopaedic Oncology Introduction
11.1.4 Stryker Corporation Revenue in Orthopaedic Oncology Business (2017-2022)
11.1.5 Stryker Corporation Recent Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Details
11.2.2 Amgen Inc. Business Overview
11.2.3 Amgen Inc. Orthopaedic Oncology Introduction
11.2.4 Amgen Inc. Revenue in Orthopaedic Oncology Business (2017-2022)
11.2.5 Amgen Inc. Recent Developments
11.3 Tyco Electronics UK Holdings Ltd.
11.3.1 Tyco Electronics UK Holdings Ltd. Company Details
11.3.2 Tyco Electronics UK Holdings Ltd. Business Overview
11.3.3 Tyco Electronics UK Holdings Ltd. Orthopaedic Oncology Introduction
11.3.4 Tyco Electronics UK Holdings Ltd. Revenue in Orthopaedic Oncology Business (2017-2022)
11.3.5 Tyco Electronics UK Holdings Ltd. Recent Developments
11.4 Accentus Inc.
11.4.1 Accentus Inc. Company Details
11.4.2 Accentus Inc. Business Overview
11.4.3 Accentus Inc. Orthopaedic Oncology Introduction
11.4.4 Accentus Inc. Revenue in Orthopaedic Oncology Business (2017-2022)
11.4.5 Accentus Inc. Recent Developments
11.5 Canon Medical Systems
11.5.1 Canon Medical Systems Company Details
11.5.2 Canon Medical Systems Business Overview
11.5.3 Canon Medical Systems Orthopaedic Oncology Introduction
11.5.4 Canon Medical Systems Revenue in Orthopaedic Oncology Business (2017-2022)
11.5.5 Canon Medical Systems Recent Developments
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Company Details
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Orthopaedic Oncology Introduction
11.6.4 Siemens Healthineers Revenue in Orthopaedic Oncology Business (2017-2022)
11.6.5 Siemens Healthineers Recent Developments
11.7 MD Anderson Cancer Center
11.7.1 MD Anderson Cancer Center Company Details
11.7.2 MD Anderson Cancer Center Business Overview
11.7.3 MD Anderson Cancer Center Orthopaedic Oncology Introduction
11.7.4 MD Anderson Cancer Center Revenue in Orthopaedic Oncology Business (2017-2022)
11.7.5 MD Anderson Cancer Center Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Orthopaedic Oncology Introduction
11.8.4 Roche Revenue in Orthopaedic Oncology Business (2017-2022)
11.8.5 Roche Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Orthopaedic Oncology Introduction
11.9.4 Novartis AG Revenue in Orthopaedic Oncology Business (2017-2022)
11.9.5 Novartis AG Recent Developments
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Details
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Orthopaedic Oncology Introduction
11.10.4 Sanofi S.A. Revenue in Orthopaedic Oncology Business (2017-2022)
11.10.5 Sanofi S.A. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る


　

Summary

Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours.
Market Analysis and Insights: Global Orthopaedic Oncology Market
The global Orthopaedic Oncology market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Surgery accounting for % of the Orthopaedic Oncology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Orthopaedic Oncology market size is valued at US$ million in 2021, while the North America and Europe Orthopaedic Oncology are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Orthopaedic Oncology landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Orthopaedic Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Orthopaedic Oncology market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Orthopaedic Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Orthopaedic Oncology market.
Global Orthopaedic Oncology Scope and Market Size
Orthopaedic Oncology market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Orthopaedic Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Surgery
Chemotherapy
Radiation Therapy
Targeted Therapy
Segment by Application
Hospitals
Research Laboratories
By Company
Stryker Corporation
Amgen Inc.
Tyco Electronics UK Holdings Ltd.
Accentus Inc.
Canon Medical Systems
Siemens Healthineers
MD Anderson Cancer Center
Roche
Novartis AG
Sanofi S.A.
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Orthopaedic Oncology Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Surgery
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.2.5 Targeted Therapy
1.3 Market by Application
1.3.1 Global Orthopaedic Oncology Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Research Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Orthopaedic Oncology Market Perspective (2017-2028)
2.2 Orthopaedic Oncology Growth Trends by Region
2.2.1 Orthopaedic Oncology Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Orthopaedic Oncology Historic Market Size by Region (2017-2022)
2.2.3 Orthopaedic Oncology Forecasted Market Size by Region (2023-2028)
2.3 Orthopaedic Oncology Market Dynamics
2.3.1 Orthopaedic Oncology Industry Trends
2.3.2 Orthopaedic Oncology Market Drivers
2.3.3 Orthopaedic Oncology Market Challenges
2.3.4 Orthopaedic Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Orthopaedic Oncology Players by Revenue
3.1.1 Global Top Orthopaedic Oncology Players by Revenue (2017-2022)
3.1.2 Global Orthopaedic Oncology Revenue Market Share by Players (2017-2022)
3.2 Global Orthopaedic Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Orthopaedic Oncology Revenue
3.4 Global Orthopaedic Oncology Market Concentration Ratio
3.4.1 Global Orthopaedic Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Orthopaedic Oncology Revenue in 2021
3.5 Orthopaedic Oncology Key Players Head office and Area Served
3.6 Key Players Orthopaedic Oncology Product Solution and Service
3.7 Date of Enter into Orthopaedic Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Orthopaedic Oncology Breakdown Data by Type
4.1 Global Orthopaedic Oncology Historic Market Size by Type (2017-2022)
4.2 Global Orthopaedic Oncology Forecasted Market Size by Type (2023-2028)
5 Orthopaedic Oncology Breakdown Data by Application
5.1 Global Orthopaedic Oncology Historic Market Size by Application (2017-2022)
5.2 Global Orthopaedic Oncology Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Orthopaedic Oncology Market Size (2017-2028)
6.2 North America Orthopaedic Oncology Market Size by Type
6.2.1 North America Orthopaedic Oncology Market Size by Type (2017-2022)
6.2.2 North America Orthopaedic Oncology Market Size by Type (2023-2028)
6.2.3 North America Orthopaedic Oncology Market Share by Type (2017-2028)
6.3 North America Orthopaedic Oncology Market Size by Application
6.3.1 North America Orthopaedic Oncology Market Size by Application (2017-2022)
6.3.2 North America Orthopaedic Oncology Market Size by Application (2023-2028)
6.3.3 North America Orthopaedic Oncology Market Share by Application (2017-2028)
6.4 North America Orthopaedic Oncology Market Size by Country
6.4.1 North America Orthopaedic Oncology Market Size by Country (2017-2022)
6.4.2 North America Orthopaedic Oncology Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Orthopaedic Oncology Market Size (2017-2028)
7.2 Europe Orthopaedic Oncology Market Size by Type
7.2.1 Europe Orthopaedic Oncology Market Size by Type (2017-2022)
7.2.2 Europe Orthopaedic Oncology Market Size by Type (2023-2028)
7.2.3 Europe Orthopaedic Oncology Market Share by Type (2017-2028)
7.3 Europe Orthopaedic Oncology Market Size by Application
7.3.1 Europe Orthopaedic Oncology Market Size by Application (2017-2022)
7.3.2 Europe Orthopaedic Oncology Market Size by Application (2023-2028)
7.3.3 Europe Orthopaedic Oncology Market Share by Application (2017-2028)
7.4 Europe Orthopaedic Oncology Market Size by Country
7.4.1 Europe Orthopaedic Oncology Market Size by Country (2017-2022)
7.4.2 Europe Orthopaedic Oncology Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Orthopaedic Oncology Market Size (2017-2028)
8.2 Asia-Pacific Orthopaedic Oncology Market Size by Type
8.2.1 Asia-Pacific Orthopaedic Oncology Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Orthopaedic Oncology Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Orthopaedic Oncology Market Share by Type (2017-2028)
8.3 Asia-Pacific Orthopaedic Oncology Market Size by Application
8.3.1 Asia-Pacific Orthopaedic Oncology Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Orthopaedic Oncology Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Orthopaedic Oncology Market Share by Application (2017-2028)
8.4 Asia-Pacific Orthopaedic Oncology Market Size by Region
8.4.1 Asia-Pacific Orthopaedic Oncology Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Orthopaedic Oncology Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Orthopaedic Oncology Market Size (2017-2028)
9.2 Latin America Orthopaedic Oncology Market Size by Type
9.2.1 Latin America Orthopaedic Oncology Market Size by Type (2017-2022)
9.2.2 Latin America Orthopaedic Oncology Market Size by Type (2023-2028)
9.2.3 Latin America Orthopaedic Oncology Market Share by Type (2017-2028)
9.3 Latin America Orthopaedic Oncology Market Size by Application
9.3.1 Latin America Orthopaedic Oncology Market Size by Application (2017-2022)
9.3.2 Latin America Orthopaedic Oncology Market Size by Application (2023-2028)
9.3.3 Latin America Orthopaedic Oncology Market Share by Application (2017-2028)
9.4 Latin America Orthopaedic Oncology Market Size by Country
9.4.1 Latin America Orthopaedic Oncology Market Size by Country (2017-2022)
9.4.2 Latin America Orthopaedic Oncology Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Orthopaedic Oncology Market Size (2017-2028)
10.2 Middle East & Africa Orthopaedic Oncology Market Size by Type
10.2.1 Middle East & Africa Orthopaedic Oncology Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Orthopaedic Oncology Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Orthopaedic Oncology Market Share by Type (2017-2028)
10.3 Middle East & Africa Orthopaedic Oncology Market Size by Application
10.3.1 Middle East & Africa Orthopaedic Oncology Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Orthopaedic Oncology Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Orthopaedic Oncology Market Share by Application (2017-2028)
10.4 Middle East & Africa Orthopaedic Oncology Market Size by Country
10.4.1 Middle East & Africa Orthopaedic Oncology Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Orthopaedic Oncology Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Stryker Corporation
11.1.1 Stryker Corporation Company Details
11.1.2 Stryker Corporation Business Overview
11.1.3 Stryker Corporation Orthopaedic Oncology Introduction
11.1.4 Stryker Corporation Revenue in Orthopaedic Oncology Business (2017-2022)
11.1.5 Stryker Corporation Recent Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Company Details
11.2.2 Amgen Inc. Business Overview
11.2.3 Amgen Inc. Orthopaedic Oncology Introduction
11.2.4 Amgen Inc. Revenue in Orthopaedic Oncology Business (2017-2022)
11.2.5 Amgen Inc. Recent Developments
11.3 Tyco Electronics UK Holdings Ltd.
11.3.1 Tyco Electronics UK Holdings Ltd. Company Details
11.3.2 Tyco Electronics UK Holdings Ltd. Business Overview
11.3.3 Tyco Electronics UK Holdings Ltd. Orthopaedic Oncology Introduction
11.3.4 Tyco Electronics UK Holdings Ltd. Revenue in Orthopaedic Oncology Business (2017-2022)
11.3.5 Tyco Electronics UK Holdings Ltd. Recent Developments
11.4 Accentus Inc.
11.4.1 Accentus Inc. Company Details
11.4.2 Accentus Inc. Business Overview
11.4.3 Accentus Inc. Orthopaedic Oncology Introduction
11.4.4 Accentus Inc. Revenue in Orthopaedic Oncology Business (2017-2022)
11.4.5 Accentus Inc. Recent Developments
11.5 Canon Medical Systems
11.5.1 Canon Medical Systems Company Details
11.5.2 Canon Medical Systems Business Overview
11.5.3 Canon Medical Systems Orthopaedic Oncology Introduction
11.5.4 Canon Medical Systems Revenue in Orthopaedic Oncology Business (2017-2022)
11.5.5 Canon Medical Systems Recent Developments
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Company Details
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Orthopaedic Oncology Introduction
11.6.4 Siemens Healthineers Revenue in Orthopaedic Oncology Business (2017-2022)
11.6.5 Siemens Healthineers Recent Developments
11.7 MD Anderson Cancer Center
11.7.1 MD Anderson Cancer Center Company Details
11.7.2 MD Anderson Cancer Center Business Overview
11.7.3 MD Anderson Cancer Center Orthopaedic Oncology Introduction
11.7.4 MD Anderson Cancer Center Revenue in Orthopaedic Oncology Business (2017-2022)
11.7.5 MD Anderson Cancer Center Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Orthopaedic Oncology Introduction
11.8.4 Roche Revenue in Orthopaedic Oncology Business (2017-2022)
11.8.5 Roche Recent Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Orthopaedic Oncology Introduction
11.9.4 Novartis AG Revenue in Orthopaedic Oncology Business (2017-2022)
11.9.5 Novartis AG Recent Developments
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Details
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Orthopaedic Oncology Introduction
11.10.4 Sanofi S.A. Revenue in Orthopaedic Oncology Business (2017-2022)
11.10.5 Sanofi S.A. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

QYResearch社のその他分野での最新刊レポート

本レポートと同じKEY WORD（orthopaedic）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.